Mark Brosius Sells 216 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Wednesday, June 4th, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $552.07, for a total value of $118,695.05.
• On Monday, June 2nd, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $549.06, for a total value of $118,047.90.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.81, for a total value of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.00, for a total value of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total value of $12,143.34.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $557.08 on Friday. The company has a market cap of $199.67 billion, a PE ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67. The business has a 50-day simple moving average of $521.99 and a two-hundred day simple moving average of $539.26. Intuitive Surgical, Inc. has a fifty-two week low of $413.52 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the company earned $1.50 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Institutional investors have recently added to or reduced their stakes in the business. Atala Financial Inc acquired a new stake in Intuitive Surgical in the fourth quarter worth about $25,000. Chilton Capital Management LLC raised its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the last quarter. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $26,000. Global Financial Private Client LLC raised its stake in shares of Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares during the last quarter. Finally, Elite Financial Inc. purchased a new position in shares of Intuitive Surgical in the first quarter worth about $26,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research report on Monday, April 14th. Citigroup reissued a “buy” rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Piper Sandler dropped their price objective on Intuitive Surgical from $670.00 to $575.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 23rd. Finally, Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.